Results for:(83 found)
Nov 22, 2013 2:11PM on Top StocksBy MoneyShow.com

These large caps have each taken steps to boost their long-term growth prospects.

Nov 13, 2013 11:46AM on Top StocksBy MoneyShow.com

An FDA advisory board voted unanimously to approve sofosbuvir, leading to expectations that the treatment could soon get federal clearance.

Nov 11, 2013 10:07AM on Top StocksBy Jim Cramer

Apparently it's 'bad' now that retail investors have stopped pulling reams of money out of the market.

Nov 7, 2013 2:51PM on Top StocksBy StreetAuthority

With 2013 coming to an end, it may be a good idea to heed these tells as you prepare your playbook for next year.

Oct 9, 2013 9:52AM on Top StocksBy Jim Cramer

Two days ago was the wrong time to jump into these high fliers.

Sep 30, 2013 10:43AM on Top StocksBy MoneyShow.com

This closed-end fund offers exposure to both publicly traded and venture capital plays in the space.

Sep 9, 2013 9:00AM on Top StocksBy TheStockAdvisors

Already a leader in HIV treatment, this company could see additional strong growth in treating liver diseases.

Tags: GILD
Sep 5, 2013 11:59AM on Top StocksBy InvestorPlace

These stocks should weather the storms of political and economic instability.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More